Searchable abstracts of presentations at key conferences in endocrinology

ea0080OC1 | Oral Communications | UKINETS2021

Incidence, prevalence of survival of neuroendocrine neoplasia in England 1995–2018

White Benjamin E , Chandrakumaran Kandiah , Wong Kwok , Rous Brian , Bouvier Catherine , Van Hemelrijck Mieke , Srirajaskanthan Rajaventhan , Ramage John K

Introduction: Incidence of neuroendocrine neoplasia (NEN) is rising worldwide. The National Cancer Registry and Analysis Service allows accurate study of NEN in England. Aim: Calculate incidence and prevalence of NEN in England from 1995-2018. Calculate site-specific survival with multivariate analysis. Method: A population-based retrospective cohort study was performed. Data requested from NCRAS were reviewed by a steering group r...

ea0080p3 | Abstracts | UKINETS2021

Sex differences and survival of neuroendocrine neoplasia in England 2012–2018

White Benjamin E , Chandrakumaran Kandiah , Wong Kwok , Rous Brian , van Hemelrijck Mieke , Srirajaskanthan Rajaventhan , Ramage John K

Introduction: Sex differences have been noted at different sites of Neuroendocrine Neoplasia in previous registry studies across different countries. Analysis of National Cancer Registry and Analysis Service (NCRAS) data can help to clarify the significance and importance of this factor in England. Aim: To examine neuroendocrine neoplasia incidence and survival by sex, site and stage. Method: A population-based, cohort study was pe...

ea0087p1 | Poster Presentations | UKINETS2022

Second primary malignancies in patients with a neuroendocrine neoplasm in England

Russell Beth , E White Benjamin , Rous Brian , Wong Kwok , Bouvier Catherine , Srirajaskanthan Rajaventhan , Van Hemelrijck Mieke , K Ramage John

Background: Patients with neuroendocrine neoplasms (NENs) may often develop other malignancies. This study aimed to identify the frequency at which these second non-NEN malignancies occurred in England.Methods: Data was extracted from the National Cancer Registration and Analysis Service (NCRAS) on all patients diagnosed with a NEN at one of eight NEN site groups between 2012-2018: appendix, caecum, colon, lung, pancreas, rectum, small intestine and stom...